Chiesi highlights gaps in the GOLD 2017 COPD report
GOLD 2017 Report: Chiesi Farmaceutici highlights relevant gaps Chiesi Farmaceutici welcomes the recently published GOLD report but identifies three key elements in the treatment recommendations, which deserve thorough evaluation and further revision: Limited evidence base Misalignment with approved…